Asthma Clinical Trial
Official title:
Randomized Controlled Trial of Spirometry Fundamentals™ in the Primary Care Setting
| Verified date | June 2010 |
| Source | University of Washington |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
Spirometry is a recommended component of asthma diagnosis and treatment in the primary care
setting, yet few primary care providers report routine use of spirometry in the provision of
care for their asthma patients. Misclassification of asthma severity has been reported when
assessment is based on symptoms alone. This misclassification can lead to inadequate
treatment that may result in increased morbidity and increased healthcare utilization/cost.
However, even when spirometry is utilized to aid in asthma severity classification, primary
care providers have a high rate of failing to meet the quality goals for testing established
by the American Thoracic Society.
The goal of this study is to evaluate the effectiveness of the Spirometry Fundamentals™ tool
in training primary care providers and their staff in producing high-quality flow-volume
curves as compared to existing training modalities and to gather information in a
'real-world' setting that can be used to improve Spirometry Fundamentals™.
| Status | Completed |
| Enrollment | 52 |
| Est. completion date | May 2009 |
| Est. primary completion date | May 2009 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 18 Years to 90 Years |
| Eligibility |
Inclusion Criteria: - Subjects must have internet access in order to transmit spirometry curve and survey data. - Subjects must have access to a computer with Windows 2000 /Mac OS 10 or higher in order to view Spirometry Fundamentals™. - Subjects must have access to a ndd Easyone spirometer. Exclusion Criteria: - Subjects who lack internet access which will be needed to transmit study data - Subjects who lack access to a computer with Windows 2000 /Mac OS 10 or higher which will be needed to view Spirometry Fundamentals™. - Subjects who lack access to a ndd Easyone spirometer. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Washington | Seattle | Washington |
| Lead Sponsor | Collaborator |
|---|---|
| University of Washington |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Spirometry test quality | Percentage of acceptable quality spirometry tests as determined by standards set by the American Thoracic Society. | Four months for controls; six months for intervention sites | No |
| Secondary | Effect of frequency of spirometry use on primary outcome | Examined whether frequency of spirometry use related to the percent of passing testing sessions conducted by the office. | Four months for controls; six months for intervention sites | No |
| Secondary | Effect of practice location on primary outcome | Examined whether practice location (private/community, hospital/university) related to the percent of passing testing sessions conducted by the office. | Four months for controls; six months for intervention sites | No |
| Secondary | Effect of practice type on primary outcome | Examined whether practice type (pediatric/non-pediatric) related to the percent of passing testing sessions conducted by the office. | Four months for controls; six months for intervention sites | No |
| Secondary | Effect of practice structure on primary outcome | Examined whether practice structure related to the percent of passing testing sessions conducted by the office. | Four months for controls; six months for intervention sites | No |
| Secondary | Effect of months of spirometry use on primary outcome | Examined whether months of spirometry use by practice (prior to participating in study) related to the percent of passing testing sessions conducted by the office. | Four months for controls; six months for intervention sites | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|